Picture courtesy newsd.in
Toronto: The Canada Health department on Thursday updated the label on AstraZeneca vaccine warning about “very rare reports of blood clots associated with low levels of blood platelets.”
The vaccine developed by Oxford-AstraZeneca is being made by the Serum Institute of India and marketed as Covishield in India.
Health Canada, however, continues to say the vaccine is safe and that it has not received any report of blood clot till now.
Canada has received 5 lakh doses of the AstraZeneca vaccine till now.
The warning label also reads: “Also, seek immediate medical attention if you experience after a few days severe or persistent headaches or blurred vision, or experience skin bruising or pinpoint round spots beyond the site of vaccination that appears after a few days”.
Also Read: AstraZeneca Vaccine: Clots, Blood Thinners & All The Concerns Explained
Bhubaneswar: Odisha eased into the final of the 29th Senior Women’s National Football Championship for…
Puri: The Excise officials have seized brown sugar worth more than Rs 40 lakh and…
New Delhi: A row erupted after the Central government amended an election rule to prevent public…
Sambalpur: Union Home Minister Amit Shah will attend several programmes in Sambalpur during his two-day…
Bengaluru: Virat Kohli co-owned One8 Commune in Bengaluru is facing fresh troubles. The restaurant-pub has…
Baripada: The children of an Anganwadi centre had a narrow escape as a huge chunk…
This website uses cookies.